Cargando…
Effects of fluoxetine on brain-derived neurotrophic factor serum concentration and cognition in patients with vascular dementia
BACKGROUND: Selective serotonin reuptake inhibitors improve cognition in patients with stroke and increase the expression of brain-derived neurotrophic factor (BDNF) in the rat hippocampus. However, the effects of selective serotonin reuptake inhibitors on cognition and serum BDNF levels in patients...
Autores principales: | Liu, Xuan, Zhang, Junjian, Sun, Dong, Fan, Yuanteng, Zhou, Hongbin, Fu, Binfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956624/ https://www.ncbi.nlm.nih.gov/pubmed/24648723 http://dx.doi.org/10.2147/CIA.S58830 |
Ejemplares similares
-
Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study
por: Zhang, Lei, et al.
Publicado: (2021) -
Decreased Serum Brain-Derived Neurotrophic Factor Levels in Elderly Korean with Dementia
por: Lee, Jung Goo, et al.
Publicado: (2009) -
Brain-Derived Neurotrophic Factor Serum Levels and Hippocampal Volume in Mild Cognitive Impairment and Dementia due to Alzheimer Disease
por: Borba, Ericksen Mielle, et al.
Publicado: (2016) -
The effect of dietary supplementation on brain-derived neurotrophic factor and cognitive functioning in Alzheimer's dementia
por: Martin, Alicia, et al.
Publicado: (2017) -
Relationship between Brain-Derived Neurotrophic Factor and Cognitive Decline in Patients with Mild Cognitive Impairment and Dementia
por: Nikolac Perkovic, Matea, et al.
Publicado: (2023)